US equities |
TSLA $362.44 ▲+0.00% MU $931.24 ▲+0.00% SPCX $148.62 ▲+0.00% SNDK $1,394.83 ▲+0.00% SKHY $146.11 ▲+0.00% NVDA $217.23 ▲+0.00% AMD $562.23 ▲+0.00% INTC $95.22 ▼-0.16%
FinancialContent

Articles published by NanoVibronix, Inc.

< Previous 1 2 Next >
News headline image
NanoVibronix, Inc. Announces Name and Ticker Symbol Change to ENvue Medical, Inc. and ‘FEED’
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
News headline image
NanoVibronix Issues Letter to Shareholders
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
News headline image
NanoVibronix Launches “Oscar” Training Aid to Accelerate ENvue Adoption and Unlock New Revenue Opportunities
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
News headline image
NanoVibronix Announces Pricing of $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
News headline image
NanoVibronix Announces Grant of New U.S. Patent Further Expanding ENvue Medical’s Intellectual Property Portfolio
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
News headline image
NanoVibronix Announces U.S. Patent Granted to ENvue Medical for Real-Time Imaging Overlay in Navigation Technology
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
News headline image
NanoVibronix Announces Reverse Stock Split
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
News headline image
NanoVibronix Announces Financing of up to $50 Million Private Placement of Preferred Stock
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
News headline image
NanoVibronix Announces ENvue Drive – First Intelligent Robotic Platform in Development for Bedside Feeding Tube and Vascular Line Navigation
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
News headline image
NanoVibronix’s ENvue Medical Division Announces Agreement with New York Medical Center to Implement ENvue™ Navigation Systems for Enteral Feeding Tube Placement
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
News headline image
ENvue Medical Granted U.S. Patent for Pediatric Feeding Tube Guidance System
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
News headline image
NanoVibronix Announces CEO Transition
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
News headline image
NanoVibronix Responds to False Post
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
News headline image
Major Louisiana Hospital Selects ENvue System for Feeding Tube Procedures
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
News headline image
NanoVibronix Announces Closing of $10 Million Public Offering of Preferred Stock and Warrants
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
News headline image
NanoVibronix Announces Pricing of $10 Million Public Offering of Preferred Stock and Warrants
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
News headline image
NanoVibronix Announces Results from UroShield™ Case Series
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
News headline image
NanoVibronix Regains Nasdaq Compliance
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
News headline image
NanoVibronix Announces Renewal and Expansion of Distribution Agreement with Dukehill Healthcare Pty Ltd in Australia
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
News headline image
Successful Independent Study of the NanoVibronix UroShield® Device Published in the Australian and New Zealand Continence Journal
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
News headline image
NanoVibronix Announces Reverse Stock Split
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
News headline image
NanoVibronix, Inc. Announces Acquisition of ENvue Medical Holdings, Corp.
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
News headline image
NanoVibronix Advances Development of PainShield and UroShield with Completion of NextGen Prototypes
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
News headline image
NanoVibronix Announces Completion of Pilot Phase of Clinical Study of UroShield® at the University of Michigan
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
News headline image
NanoVibronix Secures $12 Million Minimum Purchase Commitment for PainShield with Extension of Distribution Agreement
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
News headline image
NanoVibronix Provides Business Update
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
News headline image
NanoVibronix Takes Next Step to Partner with Specialist Urology Company to Expand Sales of UroShield in Germany
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
News headline image
NanoVibronix Signs Letter of Intent with Potential New Distributor
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
News headline image
NanoVibronix Highlights Second Quarter Revenue Growth and Narrowing of Loss from Operations in Letter to Stockholders
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
News headline image
NanoVibronix Announces Commencement of UroShield Clinical Study at the University of Michigan
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
< Previous 1 2 Next >